Anat Stemmer-Rachamimov, M.D.


Physician Investigator (Cl)
Pathology, Research Institute
Associate Professor of Pathology
Harvard Medical School
Associate Pathologist
Pathology, Massachusetts General Hospital
MD University of Milan 1982
genes neurofibromatosis 2; meningioma; nerve sheath neoplasms; neurilemmoma; neurofibromatoses; neurofibromatosis 1; neurofibromatosis 2; neurofibromin 2; neuroma acoustic; peripheral nervous system neoplasms; schwannomatosis; tuberous sclerosis Our lab's research focuses on identifying the underlying molecular changes in the lesions and malformations associated with hereditary brain tumor syndromes (neurofibromatosis 1, neurofibromatosis 2, schwannomatosis and tuberous sclerosis), and the identification of activated pathways or events that lead to tumor progression. We are now moving from defining the molecular features and understanding the biology to more practical translational research of biomarkers and drug screens.